BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 905981)

  • 21. Comparison between the 5,6-cis and 5,6-trans isomers of 25-hydroxyvitamin D3 in chronic hypoparathyroidism.
    Offermann G; Kraft D
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):784-93. PubMed ID: 579038
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Parathyroid hormone and 25-hydroxy-cholecalciferol during hypoparathyroidism].
    Argemi B; Naim C; N'guyen K; Staub J; Gras C; Simonin R
    Nouv Presse Med; 1977 May; 6(22):1979. PubMed ID: 887398
    [No Abstract]   [Full Text] [Related]  

  • 23. [Long-term administration of 1-alpha-hydroxycholecalciferol in the treatment of postoperative hypoparathyroidism].
    Morii K; Ono M; Koide A; Tanaka K; Okamoto T
    Horumon To Rinsho; 1978 Aug; 26(8):787-94. PubMed ID: 688675
    [No Abstract]   [Full Text] [Related]  

  • 24. The management of hypoparathyroidism with 1alpha-hydroxyvitamin D3.
    Heyburn PJ; Peacock M
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():209s-214s. PubMed ID: 606418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Hypoparathyroidism in adults (author's transl)].
    Vagneur JP; Argémi B; Codaccioni JL; Simonin R
    Ann Endocrinol (Paris); 1978; 39(5):373-85. PubMed ID: 742836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effects of 1 alpha-hydroxycholecalciferol (alpha-D3) in hypoparathyroidism--comparison with dihydrotachysterol (DHT2)--multi-institutional double blind studies].
    Fujita T; Furukawa Y; Son T; Ogata E; Fujimoto Y
    Horumon To Rinsho; 1979 Jan; 27(1):99-113. PubMed ID: 218756
    [No Abstract]   [Full Text] [Related]  

  • 27. [Various types of hypoparathyroidism and their treatment].
    Okano K; Nakai R; Tomori T; Yoshikawa M
    Horumon To Rinsho; 1978 Apr; 26(4):371-7. PubMed ID: 306900
    [No Abstract]   [Full Text] [Related]  

  • 28. Increase in serum immunoreactive parathyroid hormone in a hypoparathyroid patient by 1alpha-hydroxyvitamin D3.
    Jelonek A; Kokot F; Grochowski J
    Calcif Tissue Res; 1977 May; 22 Suppl():352-4. PubMed ID: 912545
    [No Abstract]   [Full Text] [Related]  

  • 29. Calcitriol in disorders of bone and calcium metabolism.
    Riggs BL
    Clin Ther; 1980; 3(1):33-9. PubMed ID: 6893296
    [No Abstract]   [Full Text] [Related]  

  • 30. Hypoparathyroidism--a long-term follow-up experience with 1 alpha-vitamin D3 therapy.
    Halabe A; Arie R; Mimran D; Samuel R; Liberman UA
    Clin Endocrinol (Oxf); 1994 Mar; 40(3):303-7. PubMed ID: 8187292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Therapeutical effect of active vitamin D metabolites in hypoparathyroidism].
    Imai Y; Tsutsuizumi M; Fukami T; Sakaguchi K; Baba H
    Horumon To Rinsho; 1982 Dec; 30(12):1433-8. PubMed ID: 7160090
    [No Abstract]   [Full Text] [Related]  

  • 32. [Effects of 1 alpha-OH-D3 on idiopathic hypoparathyroidism].
    Maeda R; Sato K; Okamoto S; Izumi M
    Horumon To Rinsho; 1978 Oct; 26(10):1097-102. PubMed ID: 215354
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of hydrochlorothiazide on calcium metabolism in postoperative hypoparathyroidism].
    Sawicki A
    Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):501-3. PubMed ID: 1962853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug information. Etalpha].
    Madsen S; Olgaard K
    Ugeskr Laeger; 1979 Jan; 141(5):310-2. PubMed ID: 760313
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of vitamin D-resistant hypoparathyroidism with 25-hydroxycholecalciferol.
    Pak CY; DeLuca HF; Chavez de los Rios JM; Suda T; Ruskin B; Delea CS
    Arch Intern Med; 1970 Aug; 126(2):239-47. PubMed ID: 4317441
    [No Abstract]   [Full Text] [Related]  

  • 36. 1,25-Dihydroxycholecalciferol: its use in the long-term management of idiopathic hypoparathyroidism in children.
    Rosen JF; Fleischman AR; Finberg L; Eisman J; DeLuca HF
    J Clin Endocrinol Metab; 1977 Sep; 45(3):457-68. PubMed ID: 903398
    [No Abstract]   [Full Text] [Related]  

  • 37. [New trends in the treatment of hypoparathyroidism].
    Litvin Y
    Harefuah; 1976 Dec; 91(12):443-6. PubMed ID: 1022650
    [No Abstract]   [Full Text] [Related]  

  • 38. [Amicrobic pustulosis hypoparathyroidism epilepsy: treatment by 25-hydroxycholecalciferol].
    Beurey J; Weber M; Barthelme D; Vignaud JM; Chaulieu Y
    Ann Dermatol Venereol; 1980; 107(12):1145-50. PubMed ID: 7235492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 1alpha-hydroxyvitamin D3 in the long-term management of hypoparathyroidism and pseudohypoparathyroidism.
    Lewin IG; Papapoulos SE; O'Riordan JL
    Clin Endocrinol (Oxf); 1977 Dec; 7 Suppl():203s-207s. PubMed ID: 606417
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Alpha-calcidol in the treatment of pseudohypofunction of the parathyroid glands].
    Nizankowska-Błaz T; Korczowski R
    Pol Tyg Lek; 1986 Aug; 41(32):1005-6. PubMed ID: 3774617
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.